logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 18
  • 1
    Lenoble, Philippe
    Investor born in November 1971
    Individual (15 offsprings)
    Officer
    2019-06-12 ~ 2022-09-09
    OF - Director → CIF 0
  • 2
    Topper, David Joseph
    Chief Financial Officer born in June 1957
    Individual (2 offsprings)
    Officer
    2024-09-30 ~ 2025-05-06
    OF - Director → CIF 0
  • 3
    Matsuda, Masaru
    Born in March 1970
    Individual (1 offspring)
    Officer
    2023-12-06 ~ now
    OF - Director → CIF 0
  • 4
    Terlouw, Clare Elizabeth
    Head Of Ventures, Life Arc born in December 1973
    Individual (13 offsprings)
    Officer
    2021-06-10 ~ 2022-09-09
    OF - Director → CIF 0
  • 5
    Ashfield, Rebecca, Dr
    Research Scientist born in January 1967
    Individual (1 offspring)
    Officer
    2015-07-09 ~ 2022-09-09
    OF - Director → CIF 0
  • 6
    Huxley, Philip, Dr
    R&D born in November 1956
    Individual (3 offsprings)
    Officer
    2014-11-12 ~ 2022-09-09
    OF - Director → CIF 0
    Huxley, Philip, Dr
    Individual (3 offsprings)
    Officer
    2015-05-02 ~ 2022-09-09
    OF - Secretary → CIF 0
    Dr Philip Huxley
    Born in November 1956
    Individual (3 offsprings)
    Person with significant control
    2016-04-06 ~ 2022-09-09
    PE - Has significant influence or controlCIF 0
  • 7
    Vairavan, Latha
    Born in August 1977
    Individual (1 offspring)
    Officer
    2025-06-13 ~ now
    OF - Director → CIF 0
  • 8
    Moore, Matthew
    Chief Business Officer born in October 1972
    Individual (1 offspring)
    Officer
    2022-09-09 ~ 2024-05-15
    OF - Director → CIF 0
  • 9
    Burrows, Scott Loren
    Chief Financial Officer born in March 1977
    Individual (2 offsprings)
    Officer
    2022-09-09 ~ 2023-08-31
    OF - Director → CIF 0
  • 10
    Robison, Jessica Lynn
    Vice President born in August 1982
    Individual (1 offspring)
    Officer
    2023-12-06 ~ 2024-08-21
    OF - Director → CIF 0
  • 11
    Morris, Toby
    Individual (1 offspring)
    Officer
    2014-11-12 ~ 2015-05-01
    OF - Secretary → CIF 0
  • 12
    Burnett, Patrick
    Born in May 1971
    Individual (1 offspring)
    Officer
    2022-09-09 ~ now
    OF - Director → CIF 0
  • 13
    Watt, Alan Paul, Dr
    Cso born in September 1963
    Individual (12 offsprings)
    Officer
    2021-08-06 ~ 2022-09-09
    OF - Director → CIF 0
  • 14
    Blackbourn, David John, Professor
    University Professor born in October 1964
    Individual (3 offsprings)
    Officer
    2015-07-09 ~ 2022-09-09
    OF - Director → CIF 0
  • 15
    Mica, Andrea Giacomo
    Director At Oxford Technology Management born in January 1968
    Individual (12 offsprings)
    Officer
    2019-06-12 ~ 2022-09-09
    OF - Director → CIF 0
  • 16
    Holbrook, David Mark Anthony, Dr
    Head Of Seed Funds At Lifearc born in May 1960
    Individual (35 offsprings)
    Officer
    2019-06-12 ~ 2021-04-28
    OF - Director → CIF 0
    Dr David Mark Anthony Holbrook
    Born in May 1960
    Individual (35 offsprings)
    Person with significant control
    2019-06-14 ~ 2021-04-28
    PE - Ownership of shares – More than 25% but not more than 50% as a member of a firmCIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% as a member of a firmCIF 0
  • 17
    Lynton House, 7-12 Tavistock Square, London, United Kingdom
    Corporate (1 offspring)
    Person with significant control
    2019-08-06 ~ 2022-09-09
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 18
    Suite 300, 3027 Townsgate Road, Westlake Village, Ca 91361, United States
    Corporate (1 offspring)
    Person with significant control
    2022-09-09 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

DUCENTIS BIOTHERAPEUTICS LTD.

Period: 2015-07-06 ~ now
Company number: 09307415
Registered names
DUCENTIS BIOTHERAPEUTICS LTD. - now
DEUCENTIS LIMITED - 2014-11-17
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Creditors
Current, Amounts falling due within one year
-5,949,214 GBP2025-12-31
-7,912,036 GBP2024-12-31
Net Current Assets/Liabilities
-5,949,214 GBP2025-12-31
-7,912,036 GBP2024-12-31
Equity
Called up share capital
975 GBP2025-12-31
975 GBP2024-12-31
975 GBP2023-12-31
Share premium
17,152,116 GBP2025-12-31
9,252,080 GBP2024-12-31
6,114,317 GBP2023-12-31
Other miscellaneous reserve
757,032 GBP2025-12-31
757,032 GBP2024-12-31
Retained earnings (accumulated losses)
-23,859,337 GBP2025-12-31
-17,922,123 GBP2024-12-31
-10,082,800 GBP2023-12-31
Equity
-5,949,214 GBP2025-12-31
-7,912,036 GBP2024-12-31
Profit/Loss
Retained earnings (accumulated losses)
-5,937,214 GBP2025-01-01 ~ 2025-12-31
-7,839,323 GBP2024-01-01 ~ 2024-12-31
Profit/Loss
-5,937,214 GBP2025-01-01 ~ 2025-12-31
-7,839,323 GBP2024-01-01 ~ 2024-12-31
Issue of Equity Instruments
Called up share capital
0 GBP2025-01-01 ~ 2025-12-31
0 GBP2024-01-01 ~ 2024-12-31
Issue of Equity Instruments
7,900,036 GBP2025-01-01 ~ 2025-12-31
3,137,763 GBP2024-01-01 ~ 2024-12-31
Average Number of Employees
32025-01-01 ~ 2025-12-31
Other Creditors
Current
5,949,214 GBP2025-12-31
7,912,036 GBP2024-12-31
Equity
Called up share capital
975 GBP2025-12-31
975 GBP2024-12-31

  • DUCENTIS BIOTHERAPEUTICS LTD.
    Info
    TRIPOS BIOPHARMA LTD. - 2015-07-06
    DUCENTIS BIOTHERAPEUTICS LTD. - 2015-07-06
    DEUCENTIS LIMITED - 2015-07-06
    Registered number 09307415
    Suite 2, Ground Floor, Templeback,10 Temple Back, Bristol BS1 6FL
    PRIVATE LIMITED COMPANY incorporated on 2014-11-12 (11 years 5 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-02-24
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 5 April 2026 and licensed under the Open Government Licence v3.0.